Pacific Edge still spending, but US diagnostics up

Pacific Edge still spending, but US diagnostics up
Brent Melville
The cash burn continues at Pacific Edge, with a total of $14.8 million in cash in the bank at end of March, following $20.1 million of new capital raised just five months ago. Reporting a net loss of $18.9 million for the 12 months ended March 31, the Dunedin-based cancer diagnostics company said while operating revenues from test sales were up 14 percent at $4.4 million, operating expenses had also increased 5 percent to $24.1 million. This was primarily due to the impact of the weaker kiwi dollar. Cash receipts from customers improved b...

More Listed Companies

How ‘shareholder value’ became a Wall Street mantra
Policy

How ‘shareholder value’ became a Wall Street mantra

Michael Jensen inspired the transformation of capitalism. Was he a hero or a villain?

Bloomberg 13 Apr 2024
How many boards should a director sit on?
Listed Companies

Simon Robertson: How many boards should a director sit on?

An attempt to judge the composition trends in NZX boards is challenging.

Simon Robertson 13 Apr 2024
Wellington council picks Precinct for major civic square project
Property

Wellington council picks Precinct for major civic square project

Firm will fund and build the new five-star green building.

Staff reporters 11 Apr 2024
Numbers and letters for investors
Markets

Simon Robertson: Numbers and letters for investors

A plea for standardised financial reporting from NZX-listed companies.

Simon Robertson 02 Mar 2024